8-K//Current report
ANTARES PHARMA, INC. 8-K
Accession 0001140361-22-014261
CIK 0001016169operating
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 9:21 AM ET
Size
879.7 KB
Accession
0001140361-22-014261
Documents
- 8-Kny20002681x1_8k.htmPrimary
FORM 8-K
- EX-2.1ny20002681x1_ex2-1.htm
EXHIBIT 2.1
- EX-3.1ny20002681x1_ex3-1.htm
EXHIBIT 3.1
- EX-99.1ny20002681x1_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHatrs-20220412.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABatrs-20220412_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREatrs-20220412_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLny20002681x1_8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001140361-22-014261-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001016169
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 9:21 AM ET
- Size
- 879.7 KB